TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.49
-0.05 (-3.25%)
At close: Jun 26, 2025, 3:59 PM
1.51
1.34%
After-hours: Jun 26, 2025, 04:43 PM EDT
-3.25% (1D)
| Bid | 1.06 |
| Market Cap | 84.32M |
| Revenue (ttm) | 4.42M |
| Net Income (ttm) | -131.48M |
| EPS (ttm) | -1.08 |
| PE Ratio (ttm) | -1.38 |
| Forward PE | -1.44 |
| Analyst | Buy |
| Ask | 1.89 |
| Volume | 362,817 |
| Avg. Volume (20D) | 574,166 |
| Open | 1.58 |
| Previous Close | 1.54 |
| Day's Range | 1.45 - 1.69 |
| 52-Week Range | 1.02 - 7.89 |
| Beta | 0.97 |
About TCRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TCRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TCRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
TScan Therapeutics Inc. is scheduled to release its earnings on Aug 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago · https://www.defenseworld.net
Squarepoint Ops LLC Makes New $59,000 Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX)Squarepoint Ops LLC purchased a new position in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) during the fourth quarter, according to the company in its most recent disclosure w...
